Russia’s sovereign wealth fund stated that the vaccine’s efficacy was determined using data from more than 1.2 million persons who received two vaccine components between January and September 2021.Russia’s sovereign wealth fund stated that the vaccine’s efficacy was determined using data from more than 1.2 million persons who received two vaccine components between January and September 2021.Read More
